Publications by authors named "Victoria Brendel"

Claim this Profile
D
Development of p21 activated kinase-targeted multikinase inhibitors that inhibit thyroid cancer cell migration.
Yihui Ma, Samantha K McCarty, Naval P Kapuriya, Victoria J Brendel, Chaojie Wang

J Clin Endocrinol Metab· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro.
Yoon Woo Koh, Manisha H Shah, Kitty Agarwal, Samantha K McCarty, Bon Seok Koo, Victoria J Brendel

Endocr Relat Cancer· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas.
Abraham Jacob, Janet Oblinger, Matthew L Bush, Victoria Brendel, Griffin Santarelli

Laryngoscope· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.
Matthew L Bush, Janet Oblinger, Victoria Brendel, Griffin Santarelli, Jie Huang

Neuro Oncol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis